VTA

VTA extracts candidate molecular markers and expression patterns that distinguish γ-Aminobutyric acid (GABA) neuron sub-groups in the ventral tegmental area (VTA).

Key Features:

• RiboTag immunoprecipitation and RNAseq: Immunoprecipitation of tagged polyribosomes (RiboTag) followed by RNA sequencing (RNAseq) on GABA and dopamine neurons to generate comparative transcriptomes.
• Comparative transcriptomic analysis: Differential analysis identifies genes enriched specifically in VTA GABA neurons relative to dopamine neurons.
• PANTHER ontology integration: Use of the PANTHER gene ontology database to annotate and prioritize candidate marker genes.
• Allen Mouse Brain Atlas integration: Cross-referencing expression patterns with Allen Mouse Brain Atlas in situ data to refine candidate selection.
• Candidate marker set: Identification of six candidate genes: Cbln4, Rxfp3, Rora, Gpr101, Trh, and Nrp2.
• Immunolabelling validation: Selective expression patterns of candidate genes were confirmed by immunolabelling in the VTA and substantia nigra pars compacta (SNc).

Scientific Applications:

• Marker discovery: Identification of molecular markers for distinguishing GABA neuron sub-populations in the VTA.
• Cell type-specific targeting: Provision of genetic entry points for cell type-specific investigations of VTA GABA neurons.
• Neural circuit studies: Support for studies of VTA circuits involved in dopamine modulation, reward processing, and aversion, including projections to the nucleus accumbens.

Methodology:

Comparative transcriptomic analysis of RiboTag-derived RNAseq from GABA and dopamine neurons combined with PANTHER gene ontology annotation and cross-referencing to Allen Mouse Brain Atlas in situ expression data.